PPT-Testing a Monitoring and Evaluation System to Capture and Communicate the Ebola Response

Ithar Hassaballa 1 Charles Sepers 1 Stephen Fawcett 1 Davison Munodawafa 2 Peter Phori 2 Ephraim Chiriseri 2 Florence DiGennaro Reed 1 and Jerry Schultz 1 1 Department . 573845744257452574555745557444573885737657462574555745357449574605738857376574565744557445573885737657456574555745557456573885737657459574635744557441574605738857376 VHPHQ5735957347VSLW5735957347RWKHU5734757536XLGV57356 Objects contaminated with the By: Calen Dehen. “Ebola is a hemorrhagic fever of the . filovirus. family with a 50-90% fatality rate. There is no effective treatment for Ebola except for the euphemistically labeled “supportive therapy.” The virus is spread through contact with infected fluids, typically blood, and once it has infected a new patient, it rapidly attacks the internal organs and connective tissue, causes severe bleeding, vomiting, aches, mental impairments and dementia, and in severe cases, grand mal seizures. The typical cause of death is multi-organ system failure” (Jones, 2011). . Ebola in Sierra Leone, a crisis out of control. Marian . kruijzen. , . Cordaid. HealthCare Sierra Leone. Overview of the presentation. Ebola in Sierra Leone, a crisis out of control. Causes of the Ebola crisis being out of control. The Ebola virus causes an acute, serious illness which is often fatal if untreated. . The most severely affected countries are: Guinea, Sierra Leone and Liberia. These country have very weak health systems, lacking human and infrastructural resources.. Pandemics and Emerging Infections. Sarah Gilbert, Jenner Institute, University of Oxford. THE JENNER INSTITUTE. a partnership between Oxford University and . the . Pirbright. Institute . - Developing innovative vaccines. In online and blended learning platforms. An experiment with technology . Margaret Conlon. Edinburgh Napier University. Regularly used in dazzlingly large lectures….. But received some criticism…. Virus . Disease: treatment, gaps and options. Ellis Owusu-Dabo . (BSc, MB ChB. , MSc, PhD, MWACP, FGCP) . Director, . KCCR/KNUST, Kumasi. , . Ghana . www.kccr-ghana.org. . Established in . October 1997. Where did they get it?. How do you get the virus? . The EBOLA Health Commissioner. The EBOLA Health Commissioner . Understand science of disease and its transmission. Interrupt the transmission of the virus. An Overview of North Carolina’s Procedure for Ebola Contact Tracing :. Guidance, Tools, and Exercises for Public Health. Operation: Ready, Set, Go. Presented by the N.C. Communicable Disease Branch . AAMC Briefing. Dr. Jim LeDuc. Director. Galveston National Laboratory. University of Texas Medical Branch. 13 October 2015. GNL Mission. The mission of the GNL is to assist the NIAID and the nation by conducting basic and applied research designed to improve the prevention, diagnosis and treatment of naturally emerging and purposefully disseminated infectious diseases.. December 2014. Ebola . epidemics. “MSF has been working in ‘Ebola settings’ for almost 20 years, so we have an enormous amount of knowledge on safe behaviour, infection control and patient management.” - . Ebola is a hemorrhagic fever that can cause disease in humans and nonhuman primates (monkeys, gorillas, and chimpanzees). Ebola is spread through direct contact (through broken skin or unprotected mucous membranes) with:. spread through direct contact (through broken skin or mucous membranes) with infected blood and body fluids . not spread through the air or by water. Individuals are only infectious when they have symptoms, which can appear up to 21 days after exposure. Clinical Care. Part III. : . Experimental Treatments and Vaccines. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. This presentation is current . as of December, 2014. This .